However, in chronic myeloid leukemia (CML), pDCs are derived from precursors that express a low level of BCR-ABL, and develop normally and usually express the co-stimulatory antigen CD86. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.